Takeda Part Two: Destroy Evidence, Pay the Price — Eli Lily and Takeda Pharmaceutical Co. Get Hit for $9 Billion Punitive Damages Verdict

Recently, in In re Actos (Pioglitazone) Products Liability Litigation, MDL No. 11-2299, a Louisiana federal jury awarded $9 billion in punitive damages against Takeda Pharmaceutical Co. (“Takeda”) and Eli Lily & Co. (“Lily”).

Takeda Part Two: Destroy Evidence, Pay the Price — Eli Lily and Takeda Pharmaceutical Co. Get Hit for $9 Billion Punitive Damages Verdict

Takeda Part Two: Destroy Evidence, Pay the Price — Eli Lily and Takeda Pharmaceutical Co. Get Hit for $9 Billion Punitive Damages Verdict

Recently, in In re Actos (Pioglitazone) Products Liability Litigation, MDL No. 11-2299, a Louisiana federal jury awarded $9 billion in punitive damages against Takeda Pharmaceutical Co. (“Takeda”) and Eli Lily & Co. (“Lily”).